Cargando…

Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment

Inflammation is an evolutionary process that allows survival against acute infection or injury. Inflammation is also a pathophysiological condition shared by numerous chronic diseases. In addition, inflammation modulates important drug-metabolizing enzymes and transporters (DMETs), thus contributing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stanke-Labesque, Françoise, Gautier-Veyret, Elodie, Chhun, Stephanie, Guilhaumou, Romain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351663/ https://www.ncbi.nlm.nih.gov/pubmed/32659304 http://dx.doi.org/10.1016/j.pharmthera.2020.107627

Ejemplares similares

Modifications pharmacocinétiques liées à une infection aiguë. Exemples issus de la pandémie de SARS-CoV-2
por: Chavant, Anaëlle, et al.
Publicado: (2021)

Variability of Isavuconazole Trough Concentrations during Longitudinal Therapeutic Drug Monitoring
por: Bolcato, Léa, et al.
Publicado: (2022)

Variability of Tacrolimus Trough Concentration in Liver Transplant Patients: Which Role of Inflammation?
por: Chavant, Anaelle, et al.
Publicado: (2021)

Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization
por: Truffot, Aurélie, et al.
Publicado: (2021)

Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab—A Preliminary Study
por: Arrivé, Capucine, et al.
Publicado: (2023)

Combined Impact of Inflammation and Pharmacogenomic Variants on Voriconazole Trough Concentrations: A Meta-Analysis of Individual Data
por: Bolcato, Léa, et al.
Publicado: (2021)

Neglecting Plasma Protein Binding in COVID‐19 Patients Leads to a Wrong Interpretation of Lopinavir Overexposure
por: Stanke‐Labesque, Francoise, et al.
Publicado: (2021)

Leukotriene Production Is Increased in Abdominal Obesity
por: Bäck, Magnus, et al.
Publicado: (2014)

NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users
por: Willeman, Théo, et al.
Publicado: (2023)

Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters
por: Bleasby, Kelly, et al.
Publicado: (2021)

Mechanisms of promiscuity among drug metabolizing enzymes and drug transporters
por: Atkins, William M.
Publicado: (2019)

The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders
por: Wu, Kuo-Chen, et al.
Publicado: (2018)

Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition
por: Abdallah, Yasmeen El Hajj, et al.
Publicado: (2023)

Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine
por: Couto, Narciso, et al.
Publicado: (2020)

Inhibitory Effect of AB-PINACA, Indazole Carboxamide Synthetic Cannabinoid, on Human Major Drug-Metabolizing Enzymes and Transporters
por: Park, Eun Jeong, et al.
Publicado: (2020)

Clinical review: Major consequences of illicit drug consumption
por: Devlin, Robert J, et al.
Publicado: (2008)

Hepatic drug-metabolizing enzymes and drug transporters in Wilson’s disease patients with liver failure
por: Szeląg-Pieniek, Sylwia, et al.
Publicado: (2021)

Editorial: Drug metabolism and transport: the Frontier of personalized medicine
por: Zhang, Junmin, et al.
Publicado: (2023)

Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy
por: Li, Jing, et al.
Publicado: (2011)

Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine
por: Ahmed, Shabbir, et al.
Publicado: (2016)

Evaluation of Pharmacogenetics of Drug-Metabolizing Enzymes and Drug Efflux Transporter in Renal Transplants Receiving Immunosuppressants
por: Sridharan, Kannan, et al.
Publicado: (2022)

Awareness of Genetic Polymorphism in Drug Metabolizing Enzymes and Transporters May Promote Personalized Type 2 Diabetes Management [Letter]
por: Zhu, Ling-Ling, et al.
Publicado: (2022)

Gene Expression Variability in Human Hepatic Drug Metabolizing Enzymes and Transporters
por: Yang, Lun, et al.
Publicado: (2013)

Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters
por: Iannaccone, Teresa, et al.
Publicado: (2021)

Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters
por: Katsube, Takayuki, et al.
Publicado: (2020)

Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage Adjustment
por: El-Khateeb, Eman, et al.
Publicado: (2021)

Effect of Genetic Variations in Drug-Metabolizing Enzymes and Drug Transporters on the Pharmacokinetics of Rifamycins: A Systematic Review
por: Sileshi, Tesemma, et al.
Publicado: (2022)

Awareness of Genetic Polymorphism in Drug Metabolizing Enzymes and Transporters May Promote Personalized Type 2 Diabetes Management [Response to Letter]
por: Williams, David M, et al.
Publicado: (2022)

In Vitro Inhibitory Effects of APINACA on Human Major Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Drug Transporters
por: Kim, Sunjoo, et al.
Publicado: (2019)

DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine
por: Arbitrio, Mariamena, et al.
Publicado: (2016)

The Systems Biology of Drug Metabolizing Enzymes and Transporters: Relevance to Quantitative Systems Pharmacology
por: Nigam, Sanjay K., et al.
Publicado: (2020)

Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline
por: Zubiaur, Pablo, et al.
Publicado: (2022)

Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective
por: Umamaheswaran, Gurusamy, et al.
Publicado: (2014)

Regulation of Human Endogenous Metabolites by Drug Transporters and Drug Metabolizing Enzymes: An Analysis of Targeted SNP-Metabolite Associations
por: Granados, Jeffry C., et al.
Publicado: (2023)

A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy
por: Gong, Christine, et al.
Publicado: (2023)

Schisandra chinensis regulates drug metabolizing enzymes and drug transporters via activation of Nrf2-mediated signaling pathway
por: He, Jin-Lian, et al.
Publicado: (2014)

Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption
por: Bergen, Andrew W., et al.
Publicado: (2015)

The influence of genetic polymorphisms in drug metabolism enzymes and transporters on the pharmacokinetics of different fluvastatin formulations
por: Xiang, Qian, et al.
Publicado: (2020)

Quantitative Proteomics of Hepatic Drug‐Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis
por: Vasilogianni, Areti‐Maria, et al.
Publicado: (2022)

Metabolism, Transport and Drug–Drug Interactions of Silymarin
por: Xie, Ying, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_301sujfb3nhbk1v76jl7svs98u